Table 5 Comparison of clinicopathological parameters of 97 locally advanced esophageal squamous cell carcinoma patients who received curative concurrent chemoradiotherapy according to VEGF day 28/day 5 ratio
Characteristics | Day 28/Day5 ratio < 1 group (N = 45) | Day 28/Day5 ratio > 1 group (N = 52) | P value |
|---|---|---|---|
Age | |||
  < 60 years | 29 (64%) | 35 (67%) | 0.77 |
  ≥ 60 years | 16 (36%) | 17 (33%) |  |
T status | |||
 1 + 2 | 8 (18%) | 7 (14%) | 0.56 |
 3 + 4 | 37 (82%) | 45 (86%) |  |
N status | |||
 0 + 1 | 14 (31%) | 17 (33%) | 0.87 |
 2 + 3 | 31 (69%) | 35 (67%) |  |
Stage | |||
 II + IIIA + IIIB | 17 (38%) | 15 (29%) | 0.35 |
 IIIC | 28 (62%) | 37 (71%) |  |
Grade | |||
 1 + 2 | 35 (78%) | 36 (69%) | 0.34 |
 3 | 10 (22%) | 16 (31%) |  |
Location | |||
 Upper | 22 (49%) | 18 (35%) | 0.15 |
 Middle + Lower | 23 (51%) | 34 (65%) |  |